← Leaderboards
Maria Gomes-Solecki
Biopeptides, Inc.
$18,983,419
Attributed
$22,985,877
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$19,884,359 · 14
CDC$3,101,518 · 1
By mechanism
R44$9,026,871 · 4
R01$6,853,192 · 3
R43$3,586,296 · 6
U01$3,101,518 · 1
R21$418,000 · 1
Top collaborators
- David A Haake4 shared
- Christine A Petersen4 shared
- Weigang Qiu3 shared
- Brian Matthew Zeglis3 shared
- Erin Egelkrout2 shared
- Grant D Brown1 shared
Others in their field
Top investigators on “Borrelia Burgdorferi”
- Erol Fikrig · Yale University$30,753,590
- Linden T Hu · Tufts Medical Center$26,794,558
- Janis J Weis · Utah State Higher Education System--University Of Utah$17,246,856
- Utpal Pal · Univ Of Maryland, College Park$14,002,425
- Jenifer L Coburn · Medical College Of Wisconsin$13,478,464
- Linda K Bockenstedt · Yale University$13,217,690
Research focus
Borrelia BurgdorferiLyme DiseaseInfectionBaseAntibodiesAffectVector-Transmitted Infectious DiseasePreventCenters For Disease Control And Prevention (U.S.)DiagnosisAntigensUnited StatesImmune ResponseTicksLaboratoriesVaccinesAreaProteinsDiagnosticTransmission ProcessOspa ProteinSensitivity And SpecificityVaccinationOrder Spirochaetales
Grant awards (43)
ImmunoPET Probes for the Imaging of Lyme Disease$552,686
R01 · FY2025 · AI
Intranasal Vaccine Against Lyme Disease$999,881
R44 · FY2024 · AI · contact PI
ImmunoPET Probes for the Imaging of Lyme Disease$556,751
R01 · FY2024 · AI
Intranasal Vaccine Against Lyme Disease$1,000,000
R44 · FY2023 · AI · contact PI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$674,307
R01 · FY2023 · AI
ImmunoPET Probes for the Imaging of Lyme Disease$565,163
R01 · FY2023 · AI
Intranasal Vaccine Against Lyme Disease$988,528
R44 · FY2022 · AI · contact PI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$693,311
R01 · FY2022 · AI
Low-cost Production of a Vaccine for Lyme Disease in Maize$310,667
R43 · FY2022 · AI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$705,010
R01 · FY2021 · AI
Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease.$295,514
R43 · FY2021 · AI · contact PI
Low-cost Production of a Vaccine for Lyme Disease in Maize$282,857
R43 · FY2021 · AI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$840,738
R01 · FY2020 · AI
Antibody isotyping for discrimination of disease stage and diagnosis of early Lyme disease.$298,123
R43 · FY2020 · AI · contact PI
Role of TLR4 in persistent Leptospira infection$190,000
R21 · FY2020 · AI · contact PI
Field trial and modeling of transmission blocking vaccine to prevent Lyme disease$733,280
R01 · FY2019 · AI
Point of care assay for serodiagnosis of Leptospirosis$300,000
R43 · FY2019 · AI · contact PI
Role of TLR4 in persistent Leptospira infection$228,000
R21 · FY2019 · AI · contact PI
Point of care assay for serodiagnosis of Leptospirosis$300,000
R43 · FY2018 · AI · contact PI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$1,000,000
R44 · FY2016 · AI · contact PI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$1,000,000
R44 · FY2015 · AI · contact PI
Outer Membrane Proteins of Pathogenic Leptospira Species$388,819
R01 · FY2015 · AI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$1,000,000
R44 · FY2014 · AI · contact PI
Outer Membrane Proteins of Pathogenic Leptospira Species$388,819
R01 · FY2014 · AI
Outer Membrane Proteins of Pathogenic Leptospira Species$365,489
R01 · FY2013 · AI
Outer Membrane Proteins of Pathogenic Leptospira Species$388,819
R01 · FY2012 · AI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$300,000
R43 · FY2012 · AI · contact PI
Multi-antigen peptide assay for the serodiagnosis of Lyme disease$719,308
R44 · FY2011 · AI · contact PI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis$620,453
U01 · FY2011 · CK · contact PI
Lab on a chip point of care assay for the rapid serodiagnosis of Lyme disease$300,000
R43 · FY2011 · AI · contact PI
Multi-antigen peptide assay for the serodiagnosis of Lyme disease$727,043
R44 · FY2010 · AI · contact PI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis$680,208
U01 · FY2010 · CK · contact PI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis$900,363
U01 · FY2009 · CK · contact PI
Multi-antigen peptide assay for the serodiagnosis of Lyme disease$583,580
R44 · FY2009 · AI · contact PI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis$801,374
U01 · FY2008 · CK · contact PI
BAIT VACCINE AGAINST LYME BORRELIOSIS$299,997
R43 · FY2008 · AI · contact PI
Multi-peptide assay for serodiagnosis of Lyme disease$299,571
R43 · FY2008 · AI · contact PI
Reservoir Targeted Vaccine fo rthe Control of Lyme Borreliosis$99,120
U01 · FY2008 · CK · contact PI
BAIT VACCINE AGAINST LYME BORRELIOSIS$299,996
R43 · FY2007 · AI · contact PI
Multi-peptide assay for serodiagnosis of Lyme disease$299,571
R43 · FY2007 · AI · contact PI
WILDLIFE ORAL VACCINE AGAINST B. BURGDORFERI$423,449
R44 · FY2006 · AI · contact PI
WILDLIFE ORAL VACCINE AGAINST B. BURGDORFERI$437,219
R44 · FY2005 · AI
WILDLIFE ORAL VACCINE AGAINST B. BURGDORFERI$147,863
R44 · FY2004 · AI